Canadian scientists discovered inexpensive magic drug for COVID-19
- Engineered Soybeans with Pig Protein: A Promising Alternative or Pandora’s Dish?
- Severe Fever with Thrombocytopenia Syndrome (SFTS): A Tick-Borne Threat with High Mortality
- Why Isolating Bananas Extends Their Shelf Life?
- This common vitamin benefits the brain and prevents cognitive decline
- New report reveals Nestlé adding sugar to infant formula sold in poor countries
- Did Cloud Seeding Unleash a Deluge in Dubai?
Canadian scientists discovered inexpensive magic drug for COVID-19 , which is highly effective and cheap
Canadian scientists discovered inexpensive magic drug for COVID-19. Recently, Canadian scientists announced that the research team has discovered a COVID-19 oral drug that can reduce the mortality rate by 44%. What much important thing is that this drug already exists and is very cheap.
According to a report by La Presse on January 22, the ColCorona study of the Montreal Heart Institute showed that they have found an effective weapon against COVID-19: colchicine, which is an oral medicine that is already well known and used to treat other diseases.
The ColCorona study was initiated in March last year. The study sample consists of 4,159 COVID-19-positive patients over 40 years old. The results of the study showed that colchicine helped to reduce the number of hospitalizations by a quarter, the need for mechanical ventilation by half, and the number of deaths by 44%.
Dr. Jean-Claude Tardif, who led the study, said that this is a “major scientific discovery” and that colchicine is the first “effective oral drug for the treatment of ambulatory patients.”
The drug may “have a significant impact on public health and may prevent COVID-19 complications for millions of patients.” As a cheap and easy-to-obtain drug, colchicine can quickly help hospitals reduce their load and reduce medical expenses in Canada and other places.
The Colcorona study initiated by the Montreal Heart Institute is one of the world’s largest anti-virus studies. This randomized, double-blind, placebo-controlled study is deployed in Canada, the United States, Europe, South America and South Africa.
Because this study is a double-blind study, neither the patient nor the research team knows whether the patient is taking a placebo or a drug, only a team independent of the research institute knows. This means that the research results have the highest level of credibility.
The governor of Quebec, Francois Legault, was very excited when he learned of the results of the study, calling it “big news.” Research on the use of colchicine to treat the COVID-19 has been carried out in Canada, the United States and other places as early as last spring. Canada has recruited 6,000 volunteers who have been infected with the COVID-19 for trials. Now the clinical data is finally available.
It is reported that colchicine is an existing powerful anti-inflammatory drug, usually used to treat pericarditis and gout. The drug has also been approved by the Oxford University research team, which is considered cheap and widely available. Now using it on COVID-19 means that the old medicine has been given a new lease of life.
For ordinary people, it can be said to be great news that there is another effective, cheap, and existing medicine that can cure COVID-19.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
